Frontlight ResearchEarly access
Trial site
Ochsner Cancer Institute
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Liver and biliary tract cancer2 trials
- Lung cancer2 trials
- Ovarian cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Multiple sclerosis1 trial
- Prostate cancer1 trial
- Phase
- Phase 11 trial
- Phase 1/21 trial
- Phase 21 trial
- Phase 31 trial
- Phase 41 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Blueprint Medicines Corporation1 trial
- ImmunoVaccine Technologies, Inc. (IMV Inc.)1 trial
- Memorial Sloan Kettering Cancer Center1 trial
- NextCure, Inc.1 trial
- Novartis Pharmaceuticals1 trial
Running trials
Closed trials
Terminated
Completed
Completed
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Site data: ClinicalTrials.govUpdated 12 Nov 2026